IPO Details
Bidding Dates
08 Mar '23 - 13 Mar '23
Minimum Investment
₹116,800 / 1 Lots ( 1600 Shares )
Price Range
₹71 - ₹73
Maximum Investment
₹116,800 / 1 Lots ( 1600 Shares )
Retail Discount
To be announced
Issue Size
₹50.10 Cr
Investor category and sub category
Qualified Institutional Buyers | Non-Institutional Investors | Retail Individual Investors |IPO Dates
Important dates with respect to IPO allotment and listing
IPO Open Date
Mar 8, 2023
IPO Close Date
Mar 13, 2023
IPO Allotment Date
Mar 16, 2023
Initiation of Refunds
Mar 19, 2023
Credit Of Shares To Demat Account
Mar 20, 2023
IPO Listing Date
Mar 21, 2023
IPO Subscription Details
| Date | QIB | NII | Retail | Total |
|---|---|---|---|---|
Day 1Mar 8, 2023 |
0.00 | 0.37 | 0.47 | 0.40 |
Day 2Mar 9, 2023 |
0.00 | 0.38 | 0.67 | 0.52 |
Day 3Mar 12, 2023 |
0.00 | 0.58 | 0.88 | 0.71 |
Day 4Mar 13, 2023 |
1.01 | 0.81 | 1.20 | 1.06 |
IPO Subscription Status Live
| Investor Category | Subscription (Times) |
|---|---|
| Qualified Institutions Buyer | 1.01 |
| Non-Institutional Buyers | 0.81 |
| Retail Investors | 1.20 |
| Employees | [.] |
| Others | [.] |
| Total | 1.06 |
About Company
The core business of Sudarshan Pharma Industries is to produce specialty chemicals and ingredients for pharma, agrochemicals, coating, paints, adhesives and several other industries.
Incorporated in 2008, SPIL supplies 50-plus pharma formulations under their brand name, including tablets, ointments, and injectables.
SPIL is involved in contract manufacturing, outsourcing and supplying generic pharma formulations and medicines to healthcare institutions, governments, NGOs, and hospitals.
Sudarshan Pharma Industries Ltd. IPO Objective
The IPO funds are primarily required to be spent on meeting working capital requirements and general corporate purposes.
Why should you invest in Sudarshan Pharma Industries Ltd. IPO?
Here are your top three reasons to consider investing in the IPO:
- They offer a diverse product portfolio, including specialty chemicals, bulk drugs, API, and pharmaceutical formulations.
- Their major international clients come from Taiwan, Oman, Uzbekistan, Bangladesh, UK and others.
- The company is expanding with a state-of-the-art manufacturing facility and expansion of distributor networks and logistic facilities in the five Indian states it covers.
Sudarshan Pharma Industries Ltd. Noteworthy highlights
- Their portfolio includes 2000 plus products in speciality chemicals, Intermediates for pharma, agrochemicals, paints, adhesives and other industrial chemicals.
- The company is exploring new markets with new products in Africa, South-East Asia, and the MENA region.
Sudarshan Pharma Industries Company Financials
| Parameters | Period Ending on September 30, 2022 (₹ Lakhs) | Year ending on 31st March, 2022 (₹ Lakhs) | Year ending on 31st March, 2021 (₹ Lakhs) |
|---|---|---|---|
| Revenue from operation | 19,589.87 | 35,709.46 | 19,335.03 |
| Profit After Tax | 360.70 | 530.37 | 267.12 |
| EBITDA | NA | 1,143.57 | 754.24 |
| EBITDA Margin | NA | NA | NA |
| EPS (Basic) | NA | 3.43 | 1.75 |
| Period Ended | Year ending on As on 31st March, 2022 | Year ending on As on 31st March, 2021 | Year ending on As on 31st March, 2020 |
| Current Asset | 12,958.00 | 8,764.35 | 4,688.21 |
| Current Liabilities | 10,104.01 | 7,122.17 | 3,433.90 |
Know before investing
Strengths
3-
Experienced promoters with 25 years plus experience in the market.
-
They have developed the skills and expertise in innovation in producing speciality chemicals, pharma formulations, medicines etc.
-
They have ultra-modern facilities for all types of manufacturing activities.
Risks
3-
SPIL made a failed attempt to launch an IPO in 2019. It is its second attempt to gain investors’ favour.
-
The enthusiasm surrounding pharma stocks is fizzing out. In such a case it could be a risk-risk but low-return offer.
-
There are legal proceedings pending against the company’s promoters and subsidiaries.
Login to Angel One App / Website & click on IPO
Select desired IPO & tap on "Apply"
Enter UPI ID, set quantity/price & submit
Accept mandate on the UPI app to complete the process
Login to Angel One App / Website
Choose IPO section on Home Page
Click IPO Orders
Chose the IPO application you want to view the status for
Sudarshan Pharma Industries IPO FAQs
Sudarshan Pharma Industries Ltd. SME IPO will open for subscription on March 9, 2023. The public offer of ₹50.10 crore consists of 6,862,400 equity shares with face value of ₹10.
The basis of allotment date is March 17, 2023.
One lot of Sudarshan Pharma Industries Ltd. IPO has 1600 shares.
The IPO will open on March 09, 2023.
Retail investors can apply for a minimum of one lot.
The listing date of Sudarshan Pharma Industries Limited on BSE SME is March 22, 2023.
You can check the allotment status of your IPO application from the Angel One app.
To check the IPO allotment status, enter the application number, DP ID, and PAN number into the app.
Listing gain is the difference between the IPO’s opening and offer prices. The listing gain is influenced by changing investors’ interests, global parameters, and short vs long-term outlooks.
The bank initially blocks the amount you bid for an IPO. It will debit the money when the shares are allotted or unblock the amount after the UPI mandate expiry date.
Login to your UPI handle and approve the payment mandate to complete the IPO application process.
You can submit only one application using one PAN card.
The minimum size of the application will be one lot of 1600 shares.
